Average Co-Inventor Count = 8.50
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Fremont Inc. (15 from 78 patents)
2. Pfizer Corporation (6 from 4,455 patents)
3. Lexicon Pharmaceuticals, Inc. (3 from 86 patents)
4. Abgenix, Inc. (3 from 32 patents)
5. Amgen Inc. (1 from 1,975 patents)
6. Pfizer Products Inc. (47 patents)
22 patents:
1. 11492411 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
2. 11059907 - Antibodies that bind Notum Pectinacetylesterase
3. 10508153 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
4. 10118968 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
5. 9096672 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
6. 9085624 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
7. 9073998 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
8. 9062113 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
9. 8742075 - Monoclonal antibodies against ANGPTL3
10. 8388971 - Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
11. 8101178 - Antibodies directed to tumor necrosis factor and uses thereof
12. 7935796 - Monoclonal antibodies against ANGPTL3
13. 7736644 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
14. 7628986 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
15. 7626012 - Nucleic acid molecules which encode antibodies that bind CD40